Literature DB >> 16835412

FDA approves shingles vaccine: herpes zoster vaccine targets older adults.

Mike Mitka.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16835412     DOI： 10.1001/jama.296.2.157

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

Review 1.  Should the UK introduce varicella vaccine?

Authors:  Marion Roderick; Athimalaipet V Ramanan; Adam Finn
Journal:  Arch Dis Child       Date:  2007-11-08       Impact factor: 3.791

Review 2.  Cost-effectiveness of vaccination against herpes zoster.

Authors:  Pieter T de Boer; Jan C Wilschut; Maarten J Postma
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  High-level cellular and humoral immune responses in Guinea pigs immunized intradermally with a heat-inactivated varicella-zoster virus vaccine.

Authors:  Julia Sarkadi; Mate Jankovics; Kinga Fodor; Zoltan Kis; Maria Takacs; Ildiko Visontai; Istvan Jankovics; Eva Gonczol
Journal:  Clin Vaccine Immunol       Date:  2015-03-18

4.  STATEMENT ON THE RECOMMENDED USE OF HERPES ZOSTER VACCINE: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)*†.

Authors:  Kevin Laupland
Journal:  Can Commun Dis Rep       Date:  2010-01-25

Review 5.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

6.  Compliance with herpes zoster vaccination in young and adult individuals in two regions of Italy.

Authors:  Antonino Parlato; Vincenzo Romano Spica; Massimo Ciccozzi; Francesca Farchi; Francesca Gallè; Valeria Di Onofrio; Elisabetta Franco; Giorgio Liguori
Journal:  BMC Public Health       Date:  2010-06-12       Impact factor: 3.295

Review 7.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

8.  Cutaneous herpes zoster.

Authors:  Sharmila Sengupta
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.663

9.  Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review.

Authors:  Edward T Chiyaka; Van T Nghiem; Lu Zhang; Abhishek Deshpande; Patricia Dolan Mullen; Phuc Le
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.558

10.  Analysis of IE62 mutations found in Varicella-Zoster virus vaccine strains for transactivation activity.

Authors:  Hyemin Ko; Gwang Myeong Lee; Ok Sarah Shin; Moon Jung Song; Chan Hee Lee; Young Eui Kim; Jin-Hyun Ahn
Journal:  J Microbiol       Date:  2018-06-01       Impact factor: 2.902
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.